A. Epenetos

发表

Elevated expression of the interleukin 4 receptor in carcinoma: a target for immunotherapy?

M. Ritter, G. Sivolapenko, B. Al Jabaari, 1989, British Journal of Cancer.

Antibody guided lymphangiography in the staging of cervical cancer.

A. Epenetos, 1985, British Journal of Cancer.

A pilot pharmacokinetic and immunoscintigraphic study with the technetium‐99m‐labeled monoclonal antibody BC‐1 directed against oncofetal fibronectin in patients with brain tumors

K. Syrigos, G. Mariani, L. Zardi, 1997, Cancer.

Enhancement of monoclonal antibody uptake in human colon tumor xenografts following irradiation.

A. Epenetos, H. Kalofonos, A. Epenetos, 1990, Cancer research.

Induction of viral and tumour specific CTL responses using antibody targeted HLA class I peptide complexes

G. Ogg, A. McMichael, A. Clayton, 2002, British Journal of Cancer.

Antigen “Suicide”: A Preliminary Study on the Induction of Specific Anti-Immunoglobulin Immunological Suppression in Vivo, Using Radiolabeled Immunoglobulin as “Lethal” Antigen

G. Paganelli, M. Ritter, A. Epenetos, 1994, The International journal of biological markers.

Effect of polarity and differentiation on antibody localization in multicellular tumour spheroid and xenograft models and its potential importance for in vivo IMMUNOTARGETING

W. Mooi, T. Krausz, D. Evans, 1989, International journal of cancer.

Localization of monoclonal antibody auai and its F(ab')2 fragments in human tumour xenografts: An autoradiographic and immunohistochemical study

W. Mooi, T. Krausz, A. Epenetos, 1988, International journal of cancer. Supplement = Journal international du cancer. Supplement.

CAMPATH-1H monoclonal antibody in therapy for previously treated low-grade non-Hodgkin's lymphomas: a phase II multicenter study. European Study Group of CAMPATH-1H Treatment in Low-Grade Non-Hodgkin's Lymphoma.

G. Brittinger, D. Huhn, U. Jaeger, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Intraperitoneal radioimmunotherapy for ovarian cancer

M. Sullivan, D. Snook, A. Epenetos, 1989 .

Intravesical administration of radiolabelled tumour-associated monoclonal antibody in bladder cancer.

K. Syrigos, G. Williams, T. Krausz, 1999, Acta oncologica.

Intraperitoneal radio‐localization of tumors pre‐targeted by biotinylated monoclonal antibodies

A. Siccardi, G. Paganelli, A. Epenetos, 1990, International journal of cancer.

Breast cancer imaging with radiolabelled peptide from complementarity-determining region of antitumour antibody

N. Courtenay-Luck, G. Sivolapenko, A. Epenetos, 1995, The Lancet.

Intraperitoneal 131I‐ and 90‐labelled monoclonal antibodies for ovarian cancer: Pharmacokinetics and normal tissue dosimetry

D. Snook, M. Myers, J. Stewart, 1988 .

Clonal rearrangement of the T‐cell receptor γ gene associated with a bizarre lymphoproliferative syndrome

G. Stamp, L. Luzzatto, L. Foroni, 1988, European journal of haematology.

A Preliminary Study of Brain Gliomas with H17E2 Monoclonal Antibody: Immunoscintigraphy and Pharmacokinetics

J. Malamitsi, A. Epenetos, G. Sivolapenko, 1989, The International journal of biological markers.

Intraperitoneally administered wY-labelled monoclonal antibodies as a third line of treatment in ovarian cancer. A phase 1-2 trial: problems encountered and possible solutions

W. Mason, W. Soutter, A. Epenetos, 2007 .

Xenogeneic monoclonal antibodies in the management of cancer: control of their in vivo immunogenicity and induction of specific unresponsiveness using an antibody-drug immunoconjugate.

M. Ritter, A. Epenetos, J. Corvalan, 1991, British Journal of Cancer.

Accessibility of Antigenic Sites Recognized by AUA1, HMFG1 and HMFG2 Monoclonal Antibodies: Its Influence on Antibody Binding of Live Cells

W. Mooi, T. Krausz, A. Epenetos, 1987, The International journal of biological markers.

Intravesical administration of indium‐111‐labelled hmfg2 monoclonal antibody in superficial bladder carcinomas

A. Bamias, G. Williams, T. Krausz, 1993, International journal of cancer.

Immunosuppression by immunoglobulin deaggregation is not effective in reducing the anti-xenogeneic immunoglobulin response: experimental and clinical studies.

M. Ritter, M. Kanariou, G. Sivolapenko, 1989, British Journal of Cancer.

Coordinate elevation of serum markers in ovarian cancer but not in benign disease

J. Schlom, R. C. Bast, W. Creasman, 1991 .

Immunoscintigraphy with 13"I-labelled H17E2 monoclonal antibody compared with conventional lymphangiography and computed tomography in the detection of metastases in patients with testicular germ cell tumours

P., J. Taylor‐Papadimitriou, A. Epenetos, 2007 .

Antibody‐guided diagnosis and therapy of malignant lesions

S. Stewart, A. Epenetos, H. Kalofonos, 1988, International journal of cancer. Supplement = Journal international du cancer. Supplement.

Immunoscintigraphy with iodine-131-labelled monoclonal antibody AUA1 in patients with transitional cell carcinoma of the bladder

S. Koritsiadis, D. Pectasidis, A. Epenetos, 2004, Urological Research.

Intravesical administration of radiolabeled antitumor monoclonal antibody in bladder carcinoma.

A. Bamias, G. Williams, T. Krausz, 1991, Cancer research.

Antibody Guided Diagnosis and Therapy of Patients with Breast Cancer

H. Kalofonos, A. Epenetos, 1987 .

Localization of biotinylated monoclonal antibody in nude mice bearing subcutaneous and intraperitoneal human tumour xenografts

W. Mooi, T. Krausz, G. Paganelli, 1988, International journal of cancer. Supplement = Journal international du cancer. Supplement.

Radiolabeled antibody combined with external radiotherapy for the treatment of head and neck cancer: reconstruction of a theoretical phantom of the larynx for radiation dose calculation to local tissues.

A. Maraveyas, N. Stafford, M. Myers, 1995, Cancer research.

Development of a novel bi-specific monoclonal antibody approach for tumour targeting

G. Stamp, R. Williams, A. Epenetos, 1999, British Journal of Cancer.

Tc-99m-labeled nonspecific polyclonal human immunoglobulin G is taken up by malignant tumors.

C. Gooden, A. Papadimitriou, C. Aktolun, 1994, Clinical nuclear medicine.

Immunoglobulin Ihhibiting Reagent®: Evaluation of a New Method for Eliminating Spurious Elevations in CA125 Caused by HAMA

A. Epenetos, S. Nicholson, G. Rustin, 1996, The International journal of biological markers.

Kinetics, quantitative analysis and radioimmunolocalization using indium-111-HMFG1 monoclonal antibody in patients with breast cancer.

J. Taylor‐Papadimitriou, J. Waxman, S. Pervez, 1989, British Journal of Cancer.

Radioimmunotherapy after chemotherapy compared to chemotherapy alone in the treatment of advanced ovarian cancer: a matched analysis.

A. Maraveyas, C. Meares, C. Gooden, 1998, Oncology reports.

Antibody-guided irradiation of advanced ovarian cancer with intraperitoneally administered radiolabeled monoclonal antibodies.

S. Stewart, P. Soutter, A. Epenetos, 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Antibody-guided irradiation of malignant pleural and pericardial effusions.

S. Stewart, J. Taylor‐Papadimitriou, T. Krausz, 1986, British journal of cancer.

Intravesical administration of tumor-associated monoclonal antibody AUA1 in transitional cell carcinoma of the bladder: a study of biodistribution

A. Epenetos, J. Elemenoglou, D. Pectasides, 2004, Urological Research.

Antibody-guided irradiation of malignant pleural and pericardial effusions.

S. Stewart, J. Taylor‐Papadimitriou, T. Krausz, 1986, British Journal of Cancer.